Dow Up 0.35% Nasdaq Down 0.02%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
16.18 Down 0.04(0.25%) Aug 20, 4:00PM EDT
|After Hours : 16.05 Down 0.13 (0.80%) Aug 20, 5:19PM EDT
Prev Close:16.22
Open:16.20
Bid:16.05 x 500
Ask:16.45 x 9100
1y Target Est:23.42
Beta:4.23
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:16.13 - 16.41
52wk Range:8.47 - 17.46
Volume:1,020,980
Avg Vol (3m):2,947,480
Market Cap:1.49B
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXDown 0.25%1.49B
BAXUp 0.16%40.76B
SHPGDown 0.06%47.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):148.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback